Literature DB >> 11602577

Differential regulation of two alternatively spliced isoforms of hypoxia-inducible factor-1 alpha in activated T lymphocytes.

D Lukashev1, C Caldwell, A Ohta, P Chen, M Sitkovsky.   

Abstract

Cell adaptation to hypoxia is partially accomplished by hypoxia-inducible transcription factor-1 (HIF-1). Here we report the hypoxia-independent up-regulation of HIF-1 alpha subunit in antigen receptor-activated T cells. This is explained by a selective up-regulation of alternatively spliced mRNA isoform I.1 that encodes the HIF-1 alpha protein without the first 12 N-terminal amino acids. We show that both short (I.1) and long (I.2) HIF-1 alpha isoforms display similar DNA binding and transcriptional activities. Major differences were observed between these two HIF-1 alpha isoforms in their expression patterns with respect to the resting and activated T lymphocytes in hypoxic and normoxic conditions. The T cell antigen receptor (TCR)-triggered activation of normal ex vivo T cells and differentiated T cells results in up-regulation of expression of I.1 isoform of HIF-1 alpha mRNA without an effect on constitutive I.2 HIF-1 alpha mRNA expression. The accumulation of I.1 HIF-1 alpha mRNA isoform in T lymphocytes is also demonstrated during cytokine-mediated inflammation in vivo, suggesting a physiological role of short HIF-1 alpha isoform in activated lymphocytes. The TCR-triggered, protein kinase C and Ca(2+)/calcineurin-mediated HIF-1 alpha I.1 mRNA induction is protein synthesis-independent, suggesting that the HIF-1 alpha I.1 gene is expressed as an immediate early response gene. Therefore, these data predict a different physiological role of short and long isoforms of HIF-1 alpha in resting and activated cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602577     DOI: 10.1074/jbc.M104782200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  Hypoxia-inducible factors regulate T cell metabolism and function.

Authors:  Anthony T Phan; Ananda W Goldrath
Journal:  Mol Immunol       Date:  2015-08-19       Impact factor: 4.407

Review 2.  Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia.

Authors:  Muhammad Zaeem Noman; Meriem Hasmim; Yosra Messai; Stéphane Terry; Claudine Kieda; Bassam Janji; Salem Chouaib
Journal:  Am J Physiol Cell Physiol       Date:  2015-08-26       Impact factor: 4.249

3.  Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation.

Authors:  YunJin Jung; Jennifer S Isaacs; Sunmin Lee; Jane Trepel; Zheng-Gang Liu; Len Neckers
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

Review 4.  Hypoxia-inducible factors in cancer stem cells and inflammation.

Authors:  Gong Peng; Yang Liu
Journal:  Trends Pharmacol Sci       Date:  2015-04-06       Impact factor: 14.819

5.  Hypoxia inducible factor 1 alpha regulates T cell receptor signal transduction.

Authors:  Aaron K Neumann; Jaeseok Yang; Mangat P Biju; Suresh K Joseph; Randall S Johnson; Volker H Haase; Bruce D Freedman; Laurence A Turka
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-14       Impact factor: 11.205

6.  Atorvastatin accelerates extracellular nucleotide degradation in human endothelial cells.

Authors:  Lana Osman; Mohamed Amrani; Charles Ilsley; Magdi H Yacoub; Ryszard T Smolenski
Journal:  Mol Cell Biochem       Date:  2007-12-25       Impact factor: 3.396

7.  Kinetic analysis of genomewide gene expression reveals molecule circuitries that control T cell activation and Th1/2 differentiation.

Authors:  Binfeng Lu; Panayiotis Zagouras; James E Fischer; Junfeng Lu; Baiyong Li; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-20       Impact factor: 11.205

Review 8.  Distinct metabolic programs in activated T cells: opportunities for selective immunomodulation.

Authors:  Daniel R Wahl; Craig A Byersdorfer; James L M Ferrara; Anthony W Opipari; Gary D Glick
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

Review 9.  Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.

Authors:  S Chouaib; M Z Noman; K Kosmatopoulos; M A Curran
Journal:  Oncogene       Date:  2016-06-27       Impact factor: 9.867

10.  Genetic deletion of the HIF-1α isoform I.1 in T cells enhances antibacterial immunity and improves survival in a murine peritonitis model.

Authors:  Peter Georgiev; Bryan G Belikoff; Stephen Hatfield; Akio Ohta; Michail V Sitkovsky; Dmitriy Lukashev
Journal:  Eur J Immunol       Date:  2013-01-31       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.